RENG News Sunday, June 1, 2014 12:59:58 PM $RENG
Post# of 17
Anacor Pharma Remains Over-Valued on Development of Inferior Drugs
at The Street - Wed Apr 16, 7:00AM CDT
Investors have yet to fully bake in risks of Anacor's two lead drugs flopping commercially.